Health News Releases

  • Today February 18
December 05, 2016 16:55
Florida’s Parrish Medical Center is the First Hospital to Commit to All 12 Actionable Patient Safety Solutions (APSS)
The Patient Safety Movement Foundation (PSMF) is very proud to announce that Parrish Medical Center in Titusville, Florida, has become the first hospital to make formal commitments that align with all
December 05, 2016 14:00
Cerevance Launched with New Technology, Drug Portfolio and $36M in Cash to Tackle Brain Diseases
Takeda Pharmaceutical Company Limited (TOKYO:4502): This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20161201006597/en/ · Takeda and
December 05, 2016 10:00
Takeda and Seattle Genetics Report Positive Phase 3 ALCANZA Clinical Trial Data of ADCETRIS® (Brentuximab Vedotin) for CD30-Expressing Cutaneous T-Cell Lymphoma
Takeda Pharmaceutical Company Limited (TSE:4502) and Seattle Genetics, Inc. (NASDAQ: SGEN) today announced that data from the Phase 3 ALCANZA clinical trial evaluating ADCETRIS (brentuximab vedotin) i
December 02, 2016 18:15
QuintilesIMS Named Best Full-service Provider CRO in 2016 Scrip Awards
QuintilesIMS has been recognized by the 2016 Scrip Awards as the Best Full-service Provider Contract Research Organization (CRO). This marks the sixth time in the last eight years that the company has
December 01, 2016 17:45
Cook Medical Opens New Distribution Centre in Singapore
Cook Medical officially opened its new state of the art South Asia Distribution Centre (SADC) in Singapore on 30th November 2016. The new facility is part of a rapid expansion of Cook Medical’s supply
December 01, 2016 11:50
Ferring Pharmaceuticals and Aché Laboratórios Farmacêuticos Collaborate on Nanotechnology R&D Platform
Ferring Pharmaceuticals and Aché Laboratórios Farmacêuticos today announced a long-term collaboration aimed at improving the bioavailability, efficacy and safety profile of oral therapeutic medicines
December 01, 2016 11:35
Takeda to Invest More Than 100 Million Euros in Dengue Vaccine Manufacturing Plant in Germany
Takeda Pharmaceutical Company Limited (TOKYO:4502) (“Takeda”) today announced that it will invest more than 100 Million Euros to build a new manufacturing plant for its dengue vaccine candidate in Sin
November 30, 2016 17:10
Patient Safety Movement Foundation Names Dr. Jannicke Mellin-Olsen to Its Board of Directors
The Patient Safety Movement Foundation (PSMF) has named long-time patient safety advocate Jannicke Mellin-Olsen, MD, DPH, to its Board of Directors. In addition to her full-time clinical post in Bærum
November 29, 2016 09:45
Boehringer Ingelheim and China Southeast University collaborate to develop new treatment approaches for hearing loss
Boehringer Ingelheim and China Southeast University Institute of Life Sciences today announced the start of a joint research project to develop new treatment approaches for hearing loss through regene
November 28, 2016 17:20
NINLARO™ (ixazomib) Receives Conditional Approval from the European Commission to Treat Multiple Myeloma
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Commission has granted conditional marketing authorization for NINLARO™ (ixazomib) capsules, indicated in combinatio
November 17, 2016 09:55
Boehringer Ingelheim welcomes central role of LAMA/LABA therapy within 2017 GOLD Strategy for COPD
Boehringer Ingelheim welcomes the updated 2017 Global Initiative for Chronic Obstructive Lung Disease (GOLD) Strategy which now positions a combination of a LAMA (long-acting anticholinergic) and a LA
November 17, 2016 09:50
Updated Phase III Results Reinforce Safety and Efficacy of Praxbind® (idarucizumab) in Urgent Situations
Boehringer Ingelheim announced updated results from data for 494 patients participating in the ongoing phase III RE-VERSE AD™ study, which showed that administration of 5g of idarucizumab immediately
November 16, 2016 13:45
Gore Global Registry for Endovascular Aortic Treatment Completes Enrollment
W. L. Gore & Associates, Inc. (Gore) today announced at the VEITHsymposium®, the completion of target enrollment in the Global Registry for Endovascular Aortic Treatment (GREAT). More than 5,000 patie
November 15, 2016 17:45
Bioventus Expands to Mexico with DUROLANE® for Knee Osteoarthritis Patients
Bioventus, a leader in orthobiologic solutions, has entered the patient care market in Mexico. This announcement reflects the company’s continued growth in international markets and its mission to par
November 15, 2016 14:00
Data on Early Onset of Efficacy for Oral OTEZLA® (apremilast) in Active Psoriatic Arthritis Presented at American College of Rheumatology
Celgene Corporation (NASDAQ: CELG) today announced findings from the ACTIVE phase 3b clinical trial of OTEZLA® (apremilast), the Company's oral, selective inhibitor of phosphodiesterase 4 (PDE4), at t
November 15, 2016 13:55
Jardiance® (empagliflozin) consistently reduced the risk of cardiovascular death in adults with type 2 diabetes regardless of the type of cardiovascular disease at baseline
New data presented at the American Heart Association Scientific Sessions 2016 showed that Jardiance® (empagliflozin) consistently reduced the risk for cardiovascular death, regardless of the type of c
November 14, 2016 17:05
New landmark study reveals adults with diabetes at unnecessary risk of vision loss
Despite vision loss being feared twice as much as other common complications of diabetes (including cardiovascular disease and stroke) a quarter of people with diabetes surveyed are not discussing eye
November 14, 2016 14:20
Masimo Receives Gates Foundation Grant to Develop Combined Pneumonia-Screening Device for High-Burden Settings
Masimo (NASDAQ: MASI) announced today, in advance of World Pneumonia Day tomorrow, that it has received a grant of $4.95 million from the Bill & Melinda Gates Foundation (BMGF). The grant will support
November 14, 2016 11:30
Patient enrolment completed for RE-DUAL PCI™ study assessing dabigatran in atrial fibrillation patients after PCI with stenting
Patient enrolment into the international Phase IIIb RE-DUAL PCI™ study is complete.[1] The study evaluates the safety and efficacy of dabigatran etexilate (marketed as Pradaxa®) in atrial fibrillation
November 09, 2016 15:50
Adare Pharmaceuticals Appoints Dr. Peter Richardson as Vice President, Research & Development and Chief Medical Officer
Adare Pharmaceuticals, Inc. announced that Dr. Peter Richardson has joined the Company as Vice President, Research & Development and Chief Medical Officer. Dr. Richardson will be responsible for leadi
November 09, 2016 15:10
Bioventus Appoints Andrew McCartney Managing Director, International for EMEA
Bioventus, a global leader in orthobiologic solutions, today announced the appointment of Andrew McCartney as Managing Director, International for Europe, Middle East and Africa (EMEA). McCartney, who
November 09, 2016 11:20
Seattle Genetics and Takeda Complete Enrollment of Phase 3 ECHELON-2 Clinical Trial Evaluating ADCETRIS® (Brentuximab Vedotin) in Frontline Mature T-cell Lymphoma
Seattle Genetics, Inc. (Nasdaq: SGEN) and Takeda Pharmaceutical Company Limited (TSE:4502) today announced completion of patient enrollment in the ECHELON-2 clinical trial. ECHELON-2 is a global phase
November 08, 2016 18:15
New European study highlights differing priorities in physician’s therapy goals when treating advanced lung cancer patients
Results from a survey analysing the prescribing behaviour of 500 European physicians treating patients with advanced non-small cell lung cancer (NSCLC) have been published in Clinical Lung Cancer. The
November 08, 2016 14:20
Philips and Masimo Sign Multi-Year Business Partnership Agreement in Patient Monitoring and Select Therapy Solutions
Royal Philips (NYSE: PHG; AEX: PHIA) and Masimo Corporation (NASDAQ: MASI) today announced a wide-ranging, multi-year business partnership involving both companies’ innovations in patient monitoring a
November 07, 2016 11:20
New Children’s Health Products Sell Out at Mannatech’s Asia MannaFest℠ 2016 Event
Mannatech®, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to changing lives to make a better world, sold out its pre-order of two newly launched children’s health product
25 per page50 per page75 per page100 per page